martes, 4 de octubre de 2016

FDA-TRACK Update: FDA looking to recruit Consumer Representatives to be involved in advisory committees

On Track: The FDA-TRACK Monthly Newsletter

FDA Track

Learn More: Consumer Representative Positions Open

The Food and Drug Administration (FDA) continually seeks input from consumers on scientific and medical issues. A key method to ensure that FDA obtains the points of views from consumers is by including Consumer Representatives on Agency advisory committees. FDA is currently recruiting to fillvacant Consumer Representative positions. This is a great opportunity for consumer advocates to be part of an important process, and we encourage all those meeting the criteria to apply.
Consumer Representatives provide the perspective of American consumers at large and do not represent their own personal expertise. The role of the Consumer Representative is to:
  • Represent the consumer perspective on issues and actions before the advisory committee;
  • Serve as a liaison between the committee and interested consumers, associations, coalitions, and consumer organizations; and
  • Facilitate dialogue with the advisory committees on scientific issues that affect consumers.
To fulfill this role, it is essential that those applying for Consumer Representative positions meet these two criteria:
  • Have an affiliation with and active participation in independent consumer or community based organizations or a history of advocating for the public interest; and
  • Demonstrate an ability to analyze scientific data and critique research design.
To learn more about FDA Advisory Committees, visit the FDA’s Advisory Committees website. To submit an application for membership, visit the Applying for Membership page or call 301-796-8220 and ask for Kimberly Hamilton. To track advisory committee vacancy rates, visit the Advisory Committees FDA-TRACK Dashboard.

What’s New in September 2016

New performance data are available for the dashboards below.
Cross Agency
  • FDA Safety and Innovation Act (FDASIA)-TRACK: FDA has completed 124 out of 140 deliverables outlined in FDASIA-TRACK, with the most recent updates focusing on the Best Pharmaceuticals for Children Act, the Pediatric Research Equity Act and FDA Advisory Committees? Check it out to learn more about the Agency’s progress on implementing FDASIA.
Center for Drug Evaluation and Research (CDER)
Center for Food Safety and Applied Nutrition (CFSAN)
Center for Veterinary Medicine (CVM)
  • CVM Dashboard: In FY16 Q3, the Office of Research (OR) received 15 jerky pet treat related complaints, of which 9 required follow-up actions. While this is a new measure that we began tracking in FY16, this represents a 55% decrease in complaints received from FY16 Q2.
Office of the Commissioner (OC)

October 2016 Upcoming Performance Data Updates

No hay comentarios: